Blackcurrants shape gut microbiota profile and reduce risk of postmenopausal osteoporosis via the gut-bone axis: Evidence from a pilot randomized controlled trial

被引:1
|
作者
Nosal, Briana M. [1 ]
Thornton, Staci N. [2 ]
Mofrad, Manije Darooghegi [1 ]
Sakaki, Junichi R. [1 ]
Mahoney, Kyle J. [2 ]
Macdonald, Zachary [2 ]
Daddi, Lauren [3 ]
Tran, Thi Dong Binh [4 ]
Weinstock, George [4 ]
Zhou, Yanjiao [3 ]
Lee, Elaine Choung-Hee [2 ]
Chun, Ock K. [1 ]
机构
[1] Univ Connecticut, Dept Nutr Sci, Storrs, CT USA
[2] Univ Connecticut, Dept Kinesiol, Storrs, CT USA
[3] Univ Connecticut Hlth, Dept Med, Farmington, CT USA
[4] Jackson Lab Genom Med, Farmington, CT USA
来源
关键词
Blackcurrant; Bone; Women; Menopause; Gut microbiota; Osteoporosis; T-CELLS; MICE; TETRANECTIN; EXPRESSION; INDUCTION; CIRRHOSIS; MARKERS; GROWTH; WOMEN; MASS;
D O I
10.1016/j.jnutbio.2024.109701
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to investigate the effects of blackcurrant (BC) on gut microbiota abundance and composition, inflammatory and immune responses, and their relationship with bone mass changes. The effects of BC on bone mineral density (BMD), gut microbiota, and blood inflammatory and immune biomarkers were evaluated using DXA, stool and fasting blood collected from a pilot three-arm, randomized, double-blind, placebo-controlled clinical trial. Fifty-one peri- and early postmenopausal women aged 45-60 years were randomly assigned into one of three treatment groups for 6 months: control, low BC (392 mg/day) and high BC (784 mg/day); and 40 women completed the trial. BC supplementation for 6 months effectively mitigated the loss of whole-body BMD ( P < .05). Six-month changes (%) in peripheral IL-1 beta beta ( P = .056) and RANKL ( P = .052) for the high BC group were marginally significantly lower than the control group. Six-month changes in whole-body BMD were inversely correlated with changes in RANKL ( P < .01). In proteome analysis, four plasma proteins showed increased expression in the high BC group: IGFBP4, tetranectin, fetuin-B, and vitamin K-dependent protein S. BC dose-dependently increased the relative abundance of Ruminococcus 2 ( P < .05), one of six bacteria correlated with BMD changes in the high BC group ( P < .05), suggesting it might be the key bacteria that drove bone protective effects. Daily BC consumption for 6 months mitigated bone loss in this population potentially through modulating the gut microbiota composition and suppressing osteoclastogenic cytokines. Larger-scale clinical trials on the potential benefits of BC and connection of Ruminococcus 2 with BMD maintenance in postmenopausal women are warranted. Trial Registration: NCT04431960, https://classic.clinicaltrials.gov/ct2/show/NCT04431960. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页数:16
相关论文
共 11 条
  • [1] Gut-bone axis perturbation: Mechanisms and interventions via gut microbiota as a primary driver of osteoporosis
    Wei, Jingyuan
    Liu, Qi
    Yuen, Ho-Yin
    Lam, Avery Chik-Him
    Jiang, Yuanyuan
    Yang, Yuhe
    Liu, Yaxiong
    Zhao, Xin
    Xiao, Long
    JOURNAL OF ORTHOPAEDIC TRANSLATION, 2025, 50 : 373 - 387
  • [2] Gut-bone axis research: unveiling the impact of gut microbiota on postmenopausal osteoporosis and osteoclasts through Mendelian randomization
    Xiao, Hefang
    Wang, Yaobin
    Chen, Yi
    Chen, Rongjin
    Yang, Chenhui
    Geng, Bin
    Xia, Yayi
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [3] Blackcurrants Reduce the Risk of Postmenopausal Osteoporosis: A Pilot Double-Blind, Randomized, Placebo-Controlled Clinical Trial
    Nosal, Briana M.
    Sakaki, Junichi R.
    Macdonald, Zachary
    Mahoney, Kyle
    Kim, Kijoon
    Madore, Matthew
    Thornton, Staci
    Tran, Thi Dong Binh
    Weinstock, George
    Lee, Elaine Choung-Hee
    Chun, Ock K.
    NUTRIENTS, 2022, 14 (23)
  • [4] Enhancing Akkermansia growth via phytohormones: a strategy to modulate the gut-bone axis in postmenopausal osteoporosis therapy
    Zhiqi Zhao
    Yixuan Deng
    Li Li
    Liying Zhu
    Xin Wang
    Haibiao Sun
    Xiaoqiong Li
    Xiaoqiang Han
    Jinjun Li
    Journal of Translational Medicine, 23 (1)
  • [5] Inulin-type prebiotics reduce serum uric acid levels via gut microbiota modulation: a randomized, controlled crossover trial in peritoneal dialysis patients
    Shuiqing He
    Qianqian Xiong
    Chong Tian
    Li Li
    Jing Zhao
    Xuechun Lin
    Xiaolei Guo
    Yuqin He
    Wangqun Liang
    Xuezhi Zuo
    Chenjiang Ying
    European Journal of Nutrition, 2022, 61 : 665 - 677
  • [6] Inulin-type prebiotics reduce serum uric acid levels via gut microbiota modulation: a randomized, controlled crossover trial in peritoneal dialysis patients
    He, Shuiqing
    Xiong, Qianqian
    Tian, Chong
    Li, Li
    Zhao, Jing
    Lin, Xuechun
    Guo, Xiaolei
    He, Yuqin
    Liang, Wangqun
    Zuo, Xuezhi
    Ying, Chenjiang
    EUROPEAN JOURNAL OF NUTRITION, 2022, 61 (02) : 665 - 677
  • [7] Healthy Dietary Pattern Cycling Affects Gut Microbiota and Cardiovascular Disease Risk Factors: Results from a Randomized Controlled Feeding Trial with Young, Healthy Adults
    Wang, Yu
    Cross, Tzu-Wen L.
    Lindemann, Stephen R.
    Tang, Minghua
    Campbell, Wayne W.
    NUTRIENTS, 2024, 16 (21)
  • [8] Differential Responders to a Mixed Meal Tolerance Test Associated with Type 2 Diabetes Risk Factors and Gut Microbiota-Data from the MEDGI-Carb Randomized Controlled Trial
    Skantze, Viktor
    Hjorth, Therese
    Wallman, Mikael
    Brunius, Carl
    Dicksved, Johan
    Pelve, Erik A.
    Esberg, Anders
    Vitale, Marilena
    Giacco, Rosalba
    Costabile, Giuseppina
    Bergia, Robert E.
    Jirstrand, Mats
    Campbell, Wayne W.
    Riccardi, Gabriele
    Landberg, Rikard
    NUTRIENTS, 2023, 15 (20)
  • [9] The pharmacological actions of Danzhi-xiaoyao-San on depression involve lysophosphatidic acid and microbiota-gut-brain axis: novel insights from a systems pharmacology analysis of a double-blind, randomized, placebo-controlled clinical trial
    Zhu, Xiuqing
    Wu, Shengwei
    Zhou, Yufang
    Xiao, Tao
    Xia, Liang
    Wang, Youtian
    Xiao, Aixiang
    Guo, Jianxiong
    Zhang, Ming
    Wen, Yuguan
    Shang, Dewei
    Yu, Lin
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (18): : 9309 - 9324
  • [10] Design of the Building Research in CRC prevention (BRIDGE-CRC) trial: a 6-month, parallel group Mediterranean diet and weight loss randomized controlled lifestyle intervention targeting the bile acid-gut microbiome axis to reduce colorectal cancer risk among African American/Black adults with obesity
    Andrew McLeod
    Patricia Wolf
    Robert S. Chapkin
    Laurie A. Davidson
    Ivan Ivanov
    Michael Berbaum
    Lauren R. Williams
    H. Rex Gaskins
    Jason Ridlon
    Jen Sanchez-Flack
    Lara Blumstein
    Linda Schiffer
    Alyshia Hamm
    Kate Cares
    Mirjana Antonic
    Beatriz Penalver Bernabe
    Marian Fitzgibbon
    Lisa Tussing-Humphreys
    Trials, 24